Samsung Biologics

207940.KO

724.32 USD

3.60

+0.50%

Overview

Last close

724.32 usd

Market cap

51.55B usd

52 week high

761.21 usd

52 week low

522.84 usd

Target price

724.32 usd

Valuation

P/E

N/A

Forward P/E

38.1679

Price/Sales

14.6544

Price/Book Value

6.3796

Enterprise Value

53.45B usd

EV/Revenue

14.6659

EV/EBITDA

32.5584

Key financials

Revenue TTM

3.64B usd

Gross Profit TTM

1.92B usd

EBITDA TTM

1.65B usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

13.13B usd

Net debt

N/A usd

About

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates through Contract Development and Manufacturing Organization (CDMO), and Biopharmaceutical Development and Commercialization segments. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and regulatory support services; and quality, biosafety and analytical testing services, as well as manufactures drug substance. In addition, it engages in the development and commercialization of biosimilar drugs; development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.